期刊文献+

冠心病血浆凝血酶、抗凝血酶和D二聚体水平分析 被引量:1

Changes of Level of Plasma TT、ATⅢ and D-D in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的:检测急性心肌梗死(acute myocardial infarction,AMI)和不稳定性心绞痛(unstable angina pectoris,UAP)病人血浆凝血酶时间(thrombin time,TT)、抗凝血酶Ⅲ(antithrombinⅢ,ATⅢ)和D二聚体(D-dimer,DD)水平,以探讨冠心病病人体内凝血?纤溶系统的变化。方法:采用全自动凝血分析仪检测150例AMI和UAP病人,50例健康对照者的TT、ATⅢ和D-D水平。结果:AMI组和UAP患者ATⅢ水平明显低于对照组(P<0.01),AMI组的D-D水平明显高于UAP组和正常组(P<0.01),三组TT水平无显著性差别(P>0.05)。结论:ATⅢ活性降低和DD水平增高是监测和鉴别AMI和UAP发生的敏感性指标。 Objective:To study the change of thrombin time(TT),antithrombin Ⅲ(ATⅢ) and D-dimer(D-D) in patients with coronary heart disease.Methods:TT、ATⅢ and D-D levels were determined in 150 patients with acute myocardial infarction(AMI) and unstable angina pectoris(UAP) by auto maticcoagulation meter;50 health-matched served as normal controls.Results:ATⅢ levels in patients with AMI and UAP were lower obviously than that in control group(P<0.01).D-D levels in patients with AMI were higher obviously than that in group with UAP and the group of control group(P<0.01).There was no significant difference in three group's TT levels.Conclusions:Decreased level of ATⅢs and increased D-D levels may be the sensitive markers for monitoring and differing the incidence of AMI and UAP.
出处 《青海医药杂志》 2007年第6期2-4,共3页 Qinghai Medical Journal
关键词 心肌梗死 不稳定性心绞痛 凝血酶时间 抗凝血酶Ⅲ D二聚体 Myocardial infarction Unstable angina pectoris Thrombin time Antithrombin Ⅲ D-dimer
  • 相关文献

参考文献4

二级参考文献34

  • 1国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 2Falciani F, Gori MG, Fedi S, et al. Elevated tissue factor and tissue factor pathway inhibitor Circulating levels in ischaemic heart disease patients. Thromb Haemost,1998,79(3):495~499.
  • 3Nishiyama K, Ogawa H, Yasue H, et al. Heparin-releasable endothelial Cell-associated tissue factor pathway inhibitor(TFPI) is increased in the Coronary Spastic angina. Thromb Res,1998,89(3):134~146.
  • 4Soejima G, Ogawa H, Yasue H, et al. Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction. Am J Cardiol,1996, 78(3):336~340.
  • 5Misumi K, Ogawa H, Yasue H, et al. Comparison of plasma tissue factor levels in unstable angina pectoris. Am J Cardiol,1998, 81(1):22~26.
  • 6Ardissino D, Merlini PA, Arlens R, et al. Tissue factor in human atherosclerotic plaques. Clin Chim Acta, 2000,291(2):235~240.
  • 7Leatham EW, Bath PM, Tooze JA, et al. Increased monocytes tissue factor expression in coronary disease .Br Heart J, 1995,73(1):10~13.
  • 8Ameri A, Kuppuswamy MN, Basu S, et al. Expression of tissue factor pathway inhibition by cultured endothelial cells in response to inflammatory mediators. Blood ,1992,79(12):3 219~3 226.
  • 9Jeske W, Hoppensteadt P, Callas P, et al. Pharmacological profiling of recombinant tissue factor pathway inhibitor. Semin thromb Hemost,1996,22(2):213~219.
  • 10[1]Lusis AJ. Atherosclerosis[J].Nature,2000,407(6801):233~241.

共引文献11

同被引文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部